BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹57 Cr | ₹4,875,430 Cr | - | ₹34 Cr | ₹16 Cr |
What is the latest Profit Before Tax of BETA DRUGS ?
| Year | Profit Before Tax |
|---|---|
| Mar2026 | ₹57 Cr |
| Mar2025 | ₹4,875,430 Cr |
| Mar2024 | - |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹16 Cr |
How is Profit Before Tax of BETA DRUGS Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹57 Cr | -100.00 | |
| Mar2025 | ₹4,875,430 Cr | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹34 Cr | 115.04 | |
| Mar2022 | ₹16 Cr | - | |
Compare Profit Before Tax of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹1,909.8 Cr | -13% | -17% | -5.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -13% |
-17% |
-5.2% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses